Nalbuphine Hydrochloride (HCL) API for Compounding Purposes

Nalbuphine Hydrochloride (HCL) API for Compounding Purposes


Nalbuphine HCLNalbuphine Hydrochloride CAS# 23277-43-2 (Nalbuphine Hydrochloride) is a synthetic opioid used commercially as an analgesic under a variety of trade names, including Nubain. It is noteworthy in part for the fact that at low dosages, it is found much more effective by women than by men, and may even increase pain in men, leading to its discontinuation in the UK in 2003.

Inquire about Nalbuphine Hydrochloride price and availability >

LGM Pharma’s team of Compounding API’s task managers have extensive knowledge of Nalbuphine Hydrochloride. Our expert knowledge of products allows us to keep a close eye on our competitors. We also adhere to the latest FDA/CVM rulings and regulations such as being CGMP Certified, and by using FDA approved supply sources with registered NDC#’s.

Our compounding products are geared specifically for the compounding industry. All of our superior quality API’s are from GMP certified and US-FDA registered manufacturers with NDC listings. All products are supplied in original manufacturers packing, with the manufacturer’s labels and NDC details.

If you require a product that is not on the compounding products list, it would be our pleasure to support you with your requirements.

Note: Compounding pharmacies should contact one of the major repackaging distributors for any specific product inquiries. We do not solicit business from pharmacies.


*Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

  • Share:

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service